RP
Regent Pacific Group Limited
RPGLF · OTC
$0.13 +2,018.64% (+$0.12)
Market Cap $1.72M
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$0.19
52.0% upside
Current Price
$0.13
Undervalued Fair Value Overvalued
According to Bulios Fair Price, RPGLF is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
5/9Valuation
36 /100
Fair P/S 4.94x
EV/FFO N/A
P/E N/A
Growth
100 /100
Growing Rev. growth 45.13%
Book val. growth N/A
EPS growth N/A
Profitability
20 /100
Weak Op. margin 1,239.08%
Gross margin 97.70%
FCF margin 1,239.37%
Quality
11 /100
Poor Asset turnover 0.61x
ROIC 755.70%
ROA 826.20%
Debt
0 /100
High Int. coverage -11.80x
Current ratio 0.07x
Debt/Assets N/A
Stability
35 /100
Moderate EPS volatility 38.47%
Beta 1.11x
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about RPGLF
Online
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Jamie Alexander Gibson
Employees
17
Headquarters
Hong Kong